Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Inc (NY: ELAN )

17.55 +0.15 (+0.83%)
Streaming Delayed Price Updated: 10:27 AM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Inc

< Previous 1 2 3 4 5 Next >
Elanco Animal Health's Debt Overview
Over the past three months, shares of Elanco Animal Health (NYSE:ELAN) rose by 14.38%. Before we understand the importance of debt, let us look at how much debt Elanco... 
Via Benzinga
Elanco To Exit Three Manufacturing Sites To Streamline Footprint
Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to sell its sites in Shawnee, Kansas, and Speke,... 
Via Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and... 
Via Benzinga
Analyzing The Price Action In Elanco Animal Health Stock Today
Elanco Animal Health's Stock Price And Volume Action Elanco Animal Health's (NYSE: 
Via Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript
ELAN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Elanco Shares Rise After Q1 Earnings Exceed Expectations, Raises FY21 Outlook
Elanco Animal Health Inc (NYSE: ELAN) has reported Q1 EPS of $0.37 higher than $0.13 reported a year ago. It surpassed analysts' estimate of $0.23 and... 
Via Benzinga
Earnings Preview for Elanco Animal Health
Elanco Animal Health (NYSE:ELAN) will be releasing its next round of earnings this Friday, May 07. For all of the relevant information, here is your guide for Friday's Q1 earnings... 
Via Benzinga
A Product Recall Crashed Elanco's Stock. Is This a Buying Opportunity?
Elanco's share price has come under pressure amid new concerns over a key product. 
Via The Motley Fool
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.